Premium
Adulteration of Drugs and Foods: Compendial Approaches to Lowering Risk
Author(s) -
Abernethy DR,
Sheehan C,
Griffiths JC,
Williams RL
Publication year - 2009
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2008.88
Subject(s) - clinical pharmacology , food and drug administration , drug , business , melamine , pharmacology , medicine , risk analysis (engineering) , toxicology , chemistry , biology , organic chemistry
The instances of adulteration of excipients in drug products with diethylene glycol (DEG), and of pet food with melamine, are well‐publicized examples of public health risks. This article describes a risk‐reduction strategy that is at the core of US food and drug law—testing to public documentary standards and using allied reference materials when needed. Clinical Pharmacology & Therapeutics (2009); 85 , 4, 444–447 doi: 10.1038/clpt.2008.88